Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) All-Cause Mortality Versus LAMA/LABA in COPD: Sensitivity Analysis of All-Cause Mortality (Secondary Endpoint) in the ETHOS Trial with Final Retrieved Vital Status Data

F.J. Martinez,K.F. Rabe,G.T. Ferguson,C. Wang,D. Singh,J.A. Wedzicha,R. Trivedi,E. St Rose,S. Ballal, J. McLaren, P. Darken, M. Aurivillius, C. Reisner, P. Dorinsky

B93. LATE BREAKING CLINICAL TRIALS IN AIRWAY DISEASES(2020)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要